Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2013
11/14/2013WO2013168007A1 Compositions and methods for the treatment of cardiovascular and neurological diseases
11/14/2013WO2013168003A1 Compositions and methods for the treatment of inflammation
11/14/2013WO2013167996A1 Compositions and methods for the treatment of metabolic syndrome
11/14/2013WO2013167992A1 Compositions and methods for the treatment of inflammatory disorders
11/14/2013WO2013167657A1 Parenteral esmolol formulation
11/14/2013WO2013167635A1 Therapeutic use of indole-dihydro-imidazole derivatives
11/14/2013WO2013167620A1 Immunomodulatory methods using notch agonists
11/14/2013WO2013167403A1 Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
11/14/2013WO2013166989A1 Thiazole compound and use thereof
11/14/2013WO2013166966A1 Polymorphs of flourine-containing deuterium-substituted omega-diphenylurea or salts thereof
11/14/2013WO2013166654A1 Permeable glycosidase inhibitors and uses thereof
11/14/2013WO2013129977A3 Pharmaceutical composition for injections having neuroprotector, antiamnaesic, antioxidant, antihypoxic and antiischaemic activity (embodiments)
11/14/2013US20130303586 Oligonucleotide compositions with enhanced efficiency
11/14/2013US20130303568 Substituted 2-Aminoacetamides and the Use Thereof
11/14/2013US20130303531 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
11/14/2013US20130303518 Methods of Inhibiting the Catalytic Activity of a Protein Kinase and of Treating a Protein Kinase Related Disorder
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/14/2013US20130303465 Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors
11/14/2013US20130303435 Smart Pro-Drugs of Serine Protease Inhibitors
11/14/2013US20130302340 Human timp-1 antibodies
11/13/2013EP2662439A1 Treatment of ischemia using stem cells
11/13/2013EP2662088A2 Anti-connexin compounds and uses thereof
11/13/2013EP2662081A1 Therapeutic use of indole-dihydro-imidazole derivatives
11/13/2013EP2661421A2 Nicotinic receptor non-competitive antagonists
11/13/2013CN103391939A Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes
11/13/2013CN103391934A Dipyridylamine derivative
11/13/2013CN103391785A Pharmaceutical compositions of tenecteplase
11/13/2013CN103391782A Medicinal agent for prevention or treatment of diseases associated with intraocular neovascularization and/or intraocular vascular hyperpermeability
11/13/2013CN103387959A Stem cell from deciduous teeth, and preparation method and application thereof
11/13/2013CN103387928A Processing method of blackberry phyllanthus emblica fruit vinegar
11/13/2013CN103387602A Novel open-chain tetrapeptide analogue and preparation method and use thereof
11/13/2013CN103387551A Thiazole compounds and uses thereof
11/13/2013CN103387535A Substituted alkynylpyridine compound, and application method and use thereof
11/13/2013CN103386136A Application of hydrophobic glucan in preparation of curcumin solubilizing agent and utilization method of hydrophobic glucan
11/13/2013CN103386130A ACE inhibitor/thiazide diuretic/5-methyltetrahydrofolate pharmaceutical composition and applications
11/13/2013CN103386122A Lumbrokinase enteric-coated tablet and preparation method thereof
11/13/2013CN103386076A Mucosa nursing antibacterial gel composition and application thereof
11/13/2013CN103386031A Drug for treating vascular dementia
11/13/2013CN103386019A Heart-strengthening pills
11/13/2013CN103386016A Blood circulation-promoting and collateral-activating pill
11/13/2013CN103385995A Traditional Chinese medicine compound for treating arrhythmia and preparation method thereof
11/13/2013CN103385991A Radix stephaniae tetrandrae mixture for veterinary use and preparation method thereof
11/13/2013CN103385984A Traditional Chinese medicine composition for treating phlebitis
11/13/2013CN103385968A Traditional Chinese medicine containing pseudo-ginseng powder and preparation method thereof
11/13/2013CN103385967A Fleece-flower root-containing traditional Chinese medicine preparation and preparation method thereof
11/13/2013CN103385966A Traditional Chinese medicine containing red ginseng and preparation method thereof
11/13/2013CN103385963A Chinese medicine preparation for treating angina pectoris caused by coronary heart disease
11/13/2013CN103385950A A preparation method for total rose laevigata michx flavones
11/13/2013CN103385941A Chinese herbal medicine pain-relieving medicinal moxibustion
11/13/2013CN103385921A Pharmaceutical composition for treating coronary heart disease, preparation and preparation method thereof
11/13/2013CN103385920A Novel application of qi-tonifying dropping pill containing Radix astragali and root of red-rooted salvia
11/13/2013CN103385913A Radix Astragali extract and its preparation method and preparation
11/13/2013CN103385904A Chrysanthemum decocting pill and preparation process thereof
11/13/2013CN103385902A Traditional Chinese medicine Herba Cirsii effective part extract, and preparation method, medicinal composition and use thereof
11/13/2013CN103385897A Chinese medicine for treating palpitation, neurasthenia and stomach diseases and preparation method and applications thereof
11/13/2013CN103385896A Preparation method of bacterial cellulose composite flavonoid compound
11/13/2013CN103385895A Method for reducing content of phenolic acid in Folium Ginkgo extract
11/13/2013CN103385887A Application of Houttuynoid C in drugs for treating ischemic brain injury
11/13/2013CN103385886A Application of Houttuynoid E in drugs for treatment and prevention of acute heart failure
11/13/2013CN103385881A Pharmaceutical composition of salviae miltiorrhizae extract for treating cardiovascular and cerebrovascular diseases and use thereof
11/13/2013CN103385870A Medical application of pregabalin
11/13/2013CN103385869A Medical application of gabapentin
11/13/2013CN103385862A Metoprolol tartrate sustained-release tablet and preparation method thereof
11/13/2013CN103385861A Trimetazidine hydrochloride sustained release tablet and preparation method thereof
11/13/2013CN103385852A Hydroxyfasudil injection and preparation method thereof
11/13/2013CN103385513A Anti-renal failure traditional Chinese medicine health-care tonic semi-fluid extract
11/13/2013CN103385322A Blood fat-reduction and blood pressure-reduction tea
11/13/2013CN102965249B Hibiscus sabdariffa nutrition wine and method for preparing same
11/13/2013CN102872258B Externally applied drug for curing thromboangiitis obliterans
11/13/2013CN102871981B Tablet medicine compound containing levetiracetam
11/13/2013CN102657818B Drug for treating infusion phlebitis and preparation method thereof
11/13/2013CN102657621B Diltiazem hydrochloride freeze-dry powder injection for injection
11/13/2013CN102579407B Preparation method for indapamide microsphere sustained release capsules
11/13/2013CN102552793B Chinese medicinal composition for treating unstable angina pectoris derived from aged coronary heart disease
11/13/2013CN102552465B Quality test method for hawthorn leaf medicine, hawthorn leaf extractives or products
11/13/2013CN102526057B Quinazoline derivative as pgk1 (phosphoglycerate kinase 1) activator
11/13/2013CN102488810B Applications of huoxiangzhengqi soft capsule serving as medicinal preparations for treating cardiovascular and cerebrovascular diseases
11/13/2013CN102396950B Health-care and health-promotion pillow
11/13/2013CN102297922B Fingerprint detecting method of volatile components in Guanxin seven-flavor dripping pills
11/13/2013CN102229562B Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
11/13/2013CN102133194B Preparation method and application of tanshinone II A solid dispersion pellets
11/13/2013CN102105448B Phenoxypyridinylamide derivatives and use thereof in the treatment of PDE4 mediated disease states
11/13/2013CN102083828B Heterocyclic compounds and compositions as C-KIT and PDGFR kinase inhibitors
11/13/2013CN101687844B Imidazole derivatives as CCR2 receptor antagonists
11/12/2013US8580838 5-membered heterocycle-based p38 kinase inhibitors
11/12/2013US8580739 Methods of reducing myocardial injury following myocardial infarction
11/12/2013US8580738 Methods for treatment of reperfusion injury and other cardiac conditions
11/12/2013US8580563 Placental stem cells
11/12/2013US8580557 Casein hydrolyzate, process for producing the same and use thereof
11/12/2013US8580308 Modafinil pharmaceutical compositions
11/12/2013CA2714357C Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
11/12/2013CA2708418C Oxazolidinones for the treatment and/or prophylaxis of heart failure
11/12/2013CA2448022C Compositions for protein delivery via the pulmonary route
11/07/2013WO2013166502A1 Regulation of cardiac sodium channels by sirt1 and sirt1 activators
11/07/2013WO2013166307A2 N,n'-di-1 naphthylguanidine hcl (nagh) and n,n'-di-p-nitrophenylguanidine hcl (nad) treatment for stroke at delayed timepoints
11/07/2013WO2013166030A2 Detecting complement activation
11/07/2013WO2013165921A2 Therapeutic use of chardonnay seed products
11/07/2013WO2013165606A1 Modulators of the relaxin receptor 1
11/07/2013WO2013164794A1 Crystalline forms of vilazodone hydrochloride
11/07/2013WO2013164773A1 Substituted pyrazole compounds as crac modulators
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 1595